PDB Short entry for 3F0T HEADER TRANSFERASE 26-OCT-08 3F0T TITLE CRYSTAL STRUCTURE OF THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE 1 TITLE 2 IN COMPLEX WITH N-METHYL-DHBT COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYMIDINE KINASE; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 45-376; COMPND 5 EC: 2.7.1.21; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HERPES SIMPLEX VIRUS (TYPE 1 / STRAIN 17); SOURCE 3 ORGANISM_COMMON: VIRUS; SOURCE 4 ORGANISM_TAXID: 10299; SOURCE 5 STRAIN: 17; SOURCE 6 GENE: TK, UL23; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRANSFERASE, THYMIDINE KINASE, DNA-SYNTHESIS, PET TRACER, ATP- KEYWDS 2 BINDING, DNA SYNTHESIS, EARLY PROTEIN, NUCLEOTIDE-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR L.PERNOT,R.PEROZZO,Y.WESTERMAIER,M.MARTIC,S.AMETAMEY,L.SCAPOZZA REVDAT 5 06-SEP-23 3F0T 1 REMARK HETSYN REVDAT 4 02-OCT-13 3F0T 1 AUTHOR REVDAT 3 03-AUG-11 3F0T 1 JRNL REVDAT 2 10-NOV-09 3F0T 1 SOURCE REVDAT 1 03-NOV-09 3F0T 0 JRNL AUTH M.MARTIC,L.PERNOT,Y.WESTERMAIER,R.PEROZZO,T.G.KRALJEVIC, JRNL AUTH 2 S.KRISTAFOR,S.RAIC-MALIC,L.SCAPOZZA,S.AMETAMEY JRNL TITL SYNTHESIS, CRYSTAL STRUCTURE, AND IN VITRO BIOLOGICAL JRNL TITL 2 EVALUATION OF C-6 PYRIMIDINE DERIVATIVES: NEW LEAD JRNL TITL 3 STRUCTURES FOR MONITORING GENE EXPRESSION IN VIVO. JRNL REF NUCLEOSIDES NUCLEOTIDES V. 30 293 2011 JRNL REF 2 NUCLEIC ACIDS JRNL REFN ISSN 1525-7770 JRNL PMID 21623543 JRNL DOI 10.1080/15257770.2011.581258 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.VOGT,R.PEROZZO,A.PAUTSCH,A.PROTA,P.SCHELLING,B.PILGER, REMARK 1 AUTH 2 G.FOLKERS,L.SCAPOZZA,G.E.SCHULZ REMARK 1 TITL NUCLEOSIDE BINDING SITE OF HERPES SIMPLEX TYPE 1 THYMIDINE REMARK 1 TITL 2 KINASE ANALYZED BY X-RAY CRYSTALLOGRAPHY. REMARK 1 REF PROTEINS V. 41 545 2000 REMARK 1 REFN ISSN 0887-3585 REMARK 1 PMID 11056041 REMARK 1 REFERENCE 2 REMARK 1 AUTH K.WILD,T.BOHNER,A.AUBRY,G.FOLKERS,G.E.SCHULZ REMARK 1 TITL THE THREE-DIMENSIONAL STRUCTURE OF THYMIDINE KINASE FROM REMARK 1 TITL 2 HERPES SIMPLEX VIRUS TYPE 1. REMARK 1 REF FEBS LETT. V. 368 289 1995 REMARK 1 REFN ISSN 0014-5793 REMARK 1 PMID 7628623 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.G.BROWN,R.VISSE,G.SANDHU,A.DAVIES,P.J.RIZKALLAH,C.MELITZ, REMARK 1 AUTH 2 W.C.SUMMERS,M.R.SANDERSON REMARK 1 TITL CRYSTAL STRUCTURES OF THE THYMIDINE KINASE FROM HERPES REMARK 1 TITL 2 SIMPLEX VIRUS TYPE-1 IN COMPLEX WITH DEOXYTHYMIDINE AND REMARK 1 TITL 3 GANCICLOVIR. REMARK 1 REF NAT.STRUCT.BIOL. V. 2 876 1995 REMARK 1 REFN ISSN 1072-8368 REMARK 1 PMID 7552712 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 48627 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2438 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2280 REMARK 3 BIN FREE R VALUE : 0.2730 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 397 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4753 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 303 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.15 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.010 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3F0T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000050003. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-NOV-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48655 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 31.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 10.00 REMARK 200 R MERGE (I) : 0.12300 REMARK 200 R SYM (I) : 0.11100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.90 REMARK 200 R MERGE FOR SHELL (I) : 0.43000 REMARK 200 R SYM FOR SHELL (I) : 0.38500 REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1E2P REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.9-1.2M LI2SO4, 1MM DTT, 0.1M HEPES REMARK 280 PH 7.5-8.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.88100 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.88100 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 56.50000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 58.68250 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 56.50000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 58.68250 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 53.88100 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 56.50000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 58.68250 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 53.88100 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 56.50000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 58.68250 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -34.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 148 REMARK 465 SER A 149 REMARK 465 SER A 150 REMARK 465 HIS A 151 REMARK 465 ALA A 152 REMARK 465 THR A 265 REMARK 465 ALA A 266 REMARK 465 VAL A 267 REMARK 465 PRO A 268 REMARK 465 PRO A 269 REMARK 465 GLN A 270 REMARK 465 GLY A 271 REMARK 465 ALA A 272 REMARK 465 GLU A 273 REMARK 465 PRO A 274 REMARK 465 GLN A 275 REMARK 465 SER A 276 REMARK 465 ASN A 277 REMARK 465 ALA A 278 REMARK 465 GLY A 279 REMARK 465 GLU A 374 REMARK 465 ALA A 375 REMARK 465 ASN A 376 REMARK 465 LYS B 45 REMARK 465 GLY B 148 REMARK 465 SER B 149 REMARK 465 SER B 150 REMARK 465 HIS B 151 REMARK 465 ALA B 152 REMARK 465 GLN B 221 REMARK 465 ARG B 222 REMARK 465 THR B 265 REMARK 465 ALA B 266 REMARK 465 VAL B 267 REMARK 465 PRO B 268 REMARK 465 PRO B 269 REMARK 465 GLN B 270 REMARK 465 GLY B 271 REMARK 465 ALA B 272 REMARK 465 GLU B 273 REMARK 465 ALA B 375 REMARK 465 ASN B 376 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH2 ARG A 320 NH2 ARG A 320 4566 1.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 154 C - N - CD ANGL. DEV. = -15.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 55 -154.27 -131.44 REMARK 500 VAL A 90 -55.46 -132.79 REMARK 500 ARG A 163 152.23 80.50 REMARK 500 LEU A 170 -61.74 -143.07 REMARK 500 VAL B 90 -53.69 -134.11 REMARK 500 ARG B 163 154.54 84.44 REMARK 500 LEU B 170 -61.13 -140.40 REMARK 500 ALA B 218 3.00 -67.74 REMARK 500 LYS B 219 -57.98 -120.43 REMARK 500 SER B 263 -113.49 -131.09 REMARK 500 PHE B 292 35.38 -96.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NCV A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NCV B 500 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E2P RELATED DB: PDB REMARK 900 THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE 1 COMPLEXED WITH REMARK 900 DHBT REMARK 900 RELATED ID: 1E2H RELATED DB: PDB REMARK 900 THYMIDINE KINASE FROM HERPES SIMPLEX VIRUS TYPE 1 IN THE APO FORM DBREF 3F0T A 45 376 UNP P03176 KITH_HHV11 45 376 DBREF 3F0T B 45 376 UNP P03176 KITH_HHV11 45 376 SEQRES 1 A 332 LYS MET PRO THR LEU LEU ARG VAL TYR ILE ASP GLY PRO SEQRES 2 A 332 HIS GLY MET GLY LYS THR THR THR THR GLN LEU LEU VAL SEQRES 3 A 332 ALA LEU GLY SER ARG ASP ASP ILE VAL TYR VAL PRO GLU SEQRES 4 A 332 PRO MET THR TYR TRP ARG VAL LEU GLY ALA SER GLU THR SEQRES 5 A 332 ILE ALA ASN ILE TYR THR THR GLN HIS ARG LEU ASP GLN SEQRES 6 A 332 GLY GLU ILE SER ALA GLY ASP ALA ALA VAL VAL MET THR SEQRES 7 A 332 SER ALA GLN ILE THR MET GLY MET PRO TYR ALA VAL THR SEQRES 8 A 332 ASP ALA VAL LEU ALA PRO HIS ILE GLY GLY GLU ALA GLY SEQRES 9 A 332 SER SER HIS ALA PRO PRO PRO ALA LEU THR LEU ILE PHE SEQRES 10 A 332 ASP ARG HIS PRO ILE ALA ALA LEU LEU CYS TYR PRO ALA SEQRES 11 A 332 ALA ARG TYR LEU MET GLY SER MET THR PRO GLN ALA VAL SEQRES 12 A 332 LEU ALA PHE VAL ALA LEU ILE PRO PRO THR LEU PRO GLY SEQRES 13 A 332 THR ASN ILE VAL LEU GLY ALA LEU PRO GLU ASP ARG HIS SEQRES 14 A 332 ILE ASP ARG LEU ALA LYS ARG GLN ARG PRO GLY GLU ARG SEQRES 15 A 332 LEU ASP LEU ALA MET LEU ALA ALA ILE ARG ARG VAL TYR SEQRES 16 A 332 GLY LEU LEU ALA ASN THR VAL ARG TYR LEU GLN CYS GLY SEQRES 17 A 332 GLY SER TRP ARG GLU ASP TRP GLY GLN LEU SER GLY THR SEQRES 18 A 332 ALA VAL PRO PRO GLN GLY ALA GLU PRO GLN SER ASN ALA SEQRES 19 A 332 GLY PRO ARG PRO HIS ILE GLY ASP THR LEU PHE THR LEU SEQRES 20 A 332 PHE ARG ALA PRO GLU LEU LEU ALA PRO ASN GLY ASP LEU SEQRES 21 A 332 TYR ASN VAL PHE ALA TRP ALA LEU ASP VAL LEU ALA LYS SEQRES 22 A 332 ARG LEU ARG SER MET HIS VAL PHE ILE LEU ASP TYR ASP SEQRES 23 A 332 GLN SER PRO ALA GLY CYS ARG ASP ALA LEU LEU GLN LEU SEQRES 24 A 332 THR SER GLY MET VAL GLN THR HIS VAL THR THR PRO GLY SEQRES 25 A 332 SER ILE PRO THR ILE CYS ASP LEU ALA ARG THR PHE ALA SEQRES 26 A 332 ARG GLU MET GLY GLU ALA ASN SEQRES 1 B 332 LYS MET PRO THR LEU LEU ARG VAL TYR ILE ASP GLY PRO SEQRES 2 B 332 HIS GLY MET GLY LYS THR THR THR THR GLN LEU LEU VAL SEQRES 3 B 332 ALA LEU GLY SER ARG ASP ASP ILE VAL TYR VAL PRO GLU SEQRES 4 B 332 PRO MET THR TYR TRP ARG VAL LEU GLY ALA SER GLU THR SEQRES 5 B 332 ILE ALA ASN ILE TYR THR THR GLN HIS ARG LEU ASP GLN SEQRES 6 B 332 GLY GLU ILE SER ALA GLY ASP ALA ALA VAL VAL MET THR SEQRES 7 B 332 SER ALA GLN ILE THR MET GLY MET PRO TYR ALA VAL THR SEQRES 8 B 332 ASP ALA VAL LEU ALA PRO HIS ILE GLY GLY GLU ALA GLY SEQRES 9 B 332 SER SER HIS ALA PRO PRO PRO ALA LEU THR LEU ILE PHE SEQRES 10 B 332 ASP ARG HIS PRO ILE ALA ALA LEU LEU CYS TYR PRO ALA SEQRES 11 B 332 ALA ARG TYR LEU MET GLY SER MET THR PRO GLN ALA VAL SEQRES 12 B 332 LEU ALA PHE VAL ALA LEU ILE PRO PRO THR LEU PRO GLY SEQRES 13 B 332 THR ASN ILE VAL LEU GLY ALA LEU PRO GLU ASP ARG HIS SEQRES 14 B 332 ILE ASP ARG LEU ALA LYS ARG GLN ARG PRO GLY GLU ARG SEQRES 15 B 332 LEU ASP LEU ALA MET LEU ALA ALA ILE ARG ARG VAL TYR SEQRES 16 B 332 GLY LEU LEU ALA ASN THR VAL ARG TYR LEU GLN CYS GLY SEQRES 17 B 332 GLY SER TRP ARG GLU ASP TRP GLY GLN LEU SER GLY THR SEQRES 18 B 332 ALA VAL PRO PRO GLN GLY ALA GLU PRO GLN SER ASN ALA SEQRES 19 B 332 GLY PRO ARG PRO HIS ILE GLY ASP THR LEU PHE THR LEU SEQRES 20 B 332 PHE ARG ALA PRO GLU LEU LEU ALA PRO ASN GLY ASP LEU SEQRES 21 B 332 TYR ASN VAL PHE ALA TRP ALA LEU ASP VAL LEU ALA LYS SEQRES 22 B 332 ARG LEU ARG SER MET HIS VAL PHE ILE LEU ASP TYR ASP SEQRES 23 B 332 GLN SER PRO ALA GLY CYS ARG ASP ALA LEU LEU GLN LEU SEQRES 24 B 332 THR SER GLY MET VAL GLN THR HIS VAL THR THR PRO GLY SEQRES 25 B 332 SER ILE PRO THR ILE CYS ASP LEU ALA ARG THR PHE ALA SEQRES 26 B 332 ARG GLU MET GLY GLU ALA ASN HET SO4 A 400 5 HET SO4 A 401 5 HET SO4 A 402 5 HET NCV A 500 16 HET SO4 B 400 5 HET SO4 B 401 5 HET SO4 B 402 5 HET NCV B 500 16 HETNAM SO4 SULFATE ION HETNAM NCV N-METHYL-6-(1,3-DIHYDROXY-ISOBUTYL)THYMINE HETSYN NCV 6-[3-HYDROXY-2-(HYDROXYMETHYL)PROPYL]-1,5- HETSYN 2 NCV DIMETHYLPYRIMIDINE-2,4(1H,3H)-DIONE; N-METHYL-DHBT FORMUL 3 SO4 6(O4 S 2-) FORMUL 6 NCV 2(C10 H16 N2 O4) FORMUL 11 HOH *303(H2 O) HELIX 1 1 LYS A 62 GLY A 73 1 12 HELIX 2 2 PRO A 84 VAL A 90 1 7 HELIX 3 3 GLU A 95 GLN A 109 1 15 HELIX 4 4 SER A 113 ALA A 140 1 28 HELIX 5 5 HIS A 164 LEU A 170 1 7 HELIX 6 6 LEU A 170 MET A 179 1 10 HELIX 7 7 THR A 183 LEU A 193 1 11 HELIX 8 8 PRO A 209 ARG A 220 1 12 HELIX 9 9 ASP A 228 CYS A 251 1 24 HELIX 10 10 SER A 254 TRP A 259 1 6 HELIX 11 11 GLY A 260 GLY A 264 5 5 HELIX 12 12 HIS A 283 ARG A 293 5 11 HELIX 13 13 ALA A 294 LEU A 298 5 5 HELIX 14 14 TYR A 305 SER A 321 1 17 HELIX 15 15 SER A 332 THR A 344 1 13 HELIX 16 16 SER A 345 MET A 347 5 3 HELIX 17 17 GLY A 356 GLY A 373 1 18 HELIX 18 18 GLY B 61 ALA B 71 1 11 HELIX 19 19 PRO B 84 VAL B 90 1 7 HELIX 20 20 GLU B 95 GLN B 109 1 15 HELIX 21 21 SER B 113 ALA B 140 1 28 HELIX 22 22 HIS B 164 LEU B 170 1 7 HELIX 23 23 LEU B 170 MET B 179 1 10 HELIX 24 24 THR B 183 ILE B 194 1 12 HELIX 25 25 PRO B 209 ALA B 218 1 10 HELIX 26 26 ASP B 228 CYS B 251 1 24 HELIX 27 27 SER B 254 TRP B 259 1 6 HELIX 28 28 GLY B 260 LEU B 262 5 3 HELIX 29 29 HIS B 283 ARG B 293 5 11 HELIX 30 30 ALA B 294 LEU B 298 5 5 HELIX 31 31 TYR B 305 SER B 321 1 17 HELIX 32 32 SER B 332 THR B 344 1 13 HELIX 33 33 SER B 345 MET B 347 5 3 HELIX 34 34 GLY B 356 GLY B 373 1 18 SHEET 1 A 5 ILE A 78 VAL A 81 0 SHEET 2 A 5 LEU A 157 ASP A 162 1 O ILE A 160 N VAL A 79 SHEET 3 A 5 THR A 48 ASP A 55 1 N VAL A 52 O PHE A 161 SHEET 4 A 5 THR A 350 VAL A 352 -1 O THR A 350 N LEU A 49 SHEET 5 A 5 ILE A 143 GLU A 146 -1 N GLY A 144 O HIS A 351 SHEET 1 B 5 ILE A 78 VAL A 81 0 SHEET 2 B 5 LEU A 157 ASP A 162 1 O ILE A 160 N VAL A 79 SHEET 3 B 5 THR A 48 ASP A 55 1 N VAL A 52 O PHE A 161 SHEET 4 B 5 ASN A 202 ALA A 207 1 O VAL A 204 N ASP A 55 SHEET 5 B 5 HIS A 323 ASP A 328 1 O PHE A 325 N LEU A 205 SHEET 1 C 5 ILE B 78 VAL B 81 0 SHEET 2 C 5 LEU B 157 ASP B 162 1 O ILE B 160 N VAL B 81 SHEET 3 C 5 THR B 48 ILE B 54 1 N VAL B 52 O PHE B 161 SHEET 4 C 5 THR B 350 VAL B 352 -1 O THR B 350 N LEU B 49 SHEET 5 C 5 ILE B 143 GLU B 146 -1 N GLY B 144 O HIS B 351 SHEET 1 D 5 ILE B 78 VAL B 81 0 SHEET 2 D 5 LEU B 157 ASP B 162 1 O ILE B 160 N VAL B 81 SHEET 3 D 5 THR B 48 ILE B 54 1 N VAL B 52 O PHE B 161 SHEET 4 D 5 ASN B 202 ALA B 207 1 O ASN B 202 N TYR B 53 SHEET 5 D 5 HIS B 323 ASP B 328 1 O LEU B 327 N LEU B 205 SITE 1 AC1 9 HOH A 23 HIS A 58 GLY A 59 MET A 60 SITE 2 AC1 9 GLY A 61 ARG A 220 ARG A 222 HOH A 456 SITE 3 AC1 9 HOH A 479 SITE 1 AC2 5 HIS A 105 ARG A 226 HOH A 461 SER B 74 SITE 2 AC2 5 ARG B 75 SITE 1 AC3 3 ARG A 212 ARG A 216 ARG B 220 SITE 1 AC4 12 HIS A 58 GLN A 125 MET A 128 ARG A 163 SITE 2 AC4 12 ALA A 168 TYR A 172 ARG A 222 HOH A 425 SITE 3 AC4 12 HOH A 428 HOH A 440 HOH A 456 HOH A 478 SITE 1 AC5 8 HIS B 58 GLY B 59 MET B 60 GLY B 61 SITE 2 AC5 8 LYS B 62 THR B 63 HOH B 409 HOH B 412 SITE 1 AC6 4 HOH B 42 LYS B 317 ARG B 320 HOH B 379 SITE 1 AC7 3 ASP A 211 ARG B 212 ARG B 220 SITE 1 AC8 12 HIS B 58 GLU B 83 TRP B 88 ILE B 100 SITE 2 AC8 12 TYR B 101 GLN B 125 MET B 128 ARG B 163 SITE 3 AC8 12 TYR B 172 ARG B 176 HOH B 396 HOH B 444 CRYST1 113.000 117.365 107.762 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008850 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008520 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009280 0.00000